Physician profile
Steven Jack Schneider
NPI 1083682769
$989.39
in general payments reported to CMS, 2019-2025
12 companies · $77.84 in 2025
The $77.84 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $45.53 · 2022: $503 · 2023: $51.38 · 2024: $74.70 · 2025: $77.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $203.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $341.74 | 2022-2025 | Artic-L 3d Ti Spinal System With Tionic Technology |
| Omniscient Neurotechnology America LTD | $177.00 | 2022 | |
| Medtronic USA, INC. | $110.81 | 2019 | |
| Livanova USA, INC. | $96.26 | 2019-2020 | |
| Stryker Corporation | $51.70 | 2020-2023 | Duramatrix, Universal Neuro 3, Na |
| Integra Lifesciences Corporation | $49.28 | 2024 | Duraseal Exact Spinal Sealant System, Codman Certas, Codman Hakim |
| Axogen | $40.53 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $35.41 | 2019 | |
| Lemaitre Vascular, INC. | $27.30 | 2023 | Anastoclip Gc 8cm (Medium) |
| Alexion Pharmaceuticals, INC. | $25.42 | 2024 | Koselugo |
| Pacira Pharmaceuticals Incorporated | $19.79 | 2022 | |
| Abbvie INC. | $14.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.